National Institutes of Health: all 11,571 studies

Page 41 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast CancerActive, not recruitingNCT02849496Phase 2
• Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy AdultsCompletedNCT02840487Phase 1
• Impact of Elastin Mediated Vascular Stiffness on End OrgansCompletedNCT02840448
• Dopamine and Motor Learning in Cerebral PalsyTerminatedNCT02839733
• Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyWithdrawnNCT02839694Phase 1
• Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
• Use of the Ask Suicide-Screening Questions (ASQ) in Pediatric Outpatient SettingsTerminatedNCT02830334
• Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision MakingCompletedNCT02829554
• CADASIL Disease DiscoveryCompletedNCT02821780
• Effects of External Ear Stimulation on Pain Perception and MoodCompletedNCT02821741Not applicable
• Collection of Tissue Blocks or Slides From Patients With CancerCompletedNCT02810405
• Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)CompletedNCT02794181
• Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT02791919Phase 1
• Helicobacter Pylori Genome Project (HpGP)TerminatedNCT02788214
• PfSPZ Challenge in Non-immune Adults in Baltimore, USACompletedNCT02780154Phase 1
• Phase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632CompletedNCT02779140Phase 1
• Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell CarcinomaCompletedNCT02775812Phase 1
• The National Myelodysplastic Syndromes (MDS) StudyCompletedNCT02775383
• PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United StatesCompletedNCT02773979Phase 1
• DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus InfectionActive, not recruitingNCT02772003Phase 1
• Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersCompletedNCT02771249Phase 1
• Suitability of Some Data Quality Controls Thresholds for Genetic Association Studies of Admixed PopulationWithdrawnNCT02770001
• Educational Impact of the NLM/National Area Health Education Center Organization (NAO) Project-SHARE Based Teen Health Information Literacy CurriculumCompletedNCT02769988
• Pediatric Patients With Metabolic or Other Genetic DisordersCompletedNCT02769949
• Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease InheritanceCompletedNCT02767986
• Study of Skin Cells That Stop Replicating (Senescent) During Wound HealingCompletedNCT02755584
• Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft FunctionCompletedNCT02752789
• Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy VolunteersCompletedNCT02750748Phase 1
• Early Life Exposures in AgricultureCompletedNCT02743481
• Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage FunctionCompletedNCT02743468
• A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy VolunteersCompletedNCT02743455Phase 1
• Natural History of Spinocerebellar Ataxia Type 7 (SCA7)Active, not recruitingNCT02741440
• Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear TestCompletedNCT02734303
• Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisWithdrawnNCT02734186Phase 4
• H2O VR for Burns 2015CompletedNCT02729259Not applicable
• Healthy Infant Development Project - Sucrose ComponentCompletedNCT02728141Not applicable
• Effect of Fasting and Refeeding on T-cell FateCompletedNCT02719899
• Oxytocin in Alcohol Use DisorderWithdrawnNCT02711189Phase 1
• Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaCompletedNCT02709226Phase 1
• Cefixime / Azithromycin pK StudyCompletedNCT02708992Phase 1
• Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)CompletedNCT02707042Phase 1
• Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer PatientsTerminatedNCT02706652
• Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue BankCompletedNCT02706639
• Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-CellsCompletedNCT02694783Early Phase 1
• Chile Biliary Longitudinal StudyCompletedNCT02692911
• Biomarker Analysis of Central Nervous System TumorsTerminatedNCT02692898
• Screening for Alpha Thalassemia in Healthy VolunteersActive, not recruitingNCT02692872
• WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)CompletedNCT02692846
• 11C-5-HTP PET in Clinical Islet TransplantationCompletedNCT02689479Not applicable
• Cholinergic Receptor Imaging in DystoniaCompletedNCT02689466
• Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus VaccineCompletedNCT02684383Phase 1
• Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell TransplantationActive, not recruitingNCT02669251Phase 1/2
• Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy PeopleCompletedNCT02669225Early Phase 1
• Tool to Assess Psycho-Social-Spiritual Healing: Cognitive InterviewingCompletedNCT02664402
• Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina FasoCompletedNCT02663700Phase 1
• Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi SarcomaActive, not recruitingNCT02659930Phase 1
• Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, MaliCompletedNCT02659566
• Uveitis/Intraocular Inflammatory Disease Biobank (iBank)CompletedNCT02656381
• Soft Tissue and Bone Development in Young GirlsCompletedNCT02654262
• Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected AdultsCompletedNCT02654080Phase 1
• CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)CompletedNCT02652546Phase 1
• Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in MaliCompletedNCT02645604
• Measuring and Improving Medication Adherence in Kidney Transplant PatientsCompletedNCT02639949Not applicable
• Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene VariationCompletedNCT02639273Phase 1
• A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte DiseasesCompletedNCT02639260Phase 1
• Liposomal Irinotecan and Veliparib in Treating Patients With Solid TumorsCompletedNCT02631733Phase 1
• CLAD Phenotype Specific Risk Factors and MechanismsCompletedNCT02631720
• Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruCompletedNCT02630082Not applicable
• High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous DiseaseActive, not recruitingNCT02629120Phase 1/2
• Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in MaliCompletedNCT02627456Phase 1
• Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast CancerWithdrawnNCT02627430Phase 1
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy AdultsCompletedNCT02624219Phase 1
• New Technology and Child HealthCompletedNCT02622035Not applicable
• Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in CambodiaCompletedNCT02612545Phase 1
• High Image Matrix CT ReconstructionCompletedNCT02610465
• Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and ChildrenCompletedNCT02601612Phase 1
• Gut Microbiota in People With Hepatocellular Carcinoma (HCC)WithdrawnNCT02599909
• Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT02599896Phase 1
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)Active, not recruitingNCT02595944Phase 3
• M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02595931Phase 1
• Nivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryTerminatedNCT02595918Phase 1
• Dose Finding Trial of MK-7075 in Children and Adults With Proteus SyndromeCompletedNCT02594215Phase 1
• Influenza A H3N2 Human Challenge Study in Healthy Adult VolunteersCompletedNCT02594189Phase 1
• H7N9 Boost in Healthy AdultsCompletedNCT02586792Phase 2
• Maternal Body Composition Regulates Placental FunctionCompletedNCT02586714
• Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in ChinaCompletedNCT02586532
• Investigating the Impact of Obesity on Pubertal Development in GirlsActive, not recruitingNCT02583646
• Evaluation of MiSeq for Microbial Identification in SpecimensCompletedNCT02578875
• PregSource: Crowdsourcing to Understand PregnancyCompletedNCT02577536
• Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy VolunteersCompletedNCT02572089Phase 1
• Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin LymphomaCompletedNCT02568553Phase 1
• Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
• Family Caregiving Role Adjustment and Dyadic MutualityCompletedNCT02566174
• Parental Irradiation of Ukrainian Cleanup Workers and Evacuees and Germline Mutations in Their Offspring (Trio Study)TerminatedNCT02566161
• Clinical and Laboratory Analysis of Familial CancerCompletedNCT02565004
• Study of Structural ImagingCompletedNCT02564991
• Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy AdultsCompletedNCT02564575Phase 1
• Follow-Up Study of People Treated for ScoliosisCompletedNCT02546479
• Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian AdultsCompletedNCT02544048
• Quantifying the Persistence of Metabolic Adaptation and Weight Regain Following Extreme Weight LossCompletedNCT02544009

← National Institutes of Health overview and focus areas